|
CVS
Nov 6, 2018 11:54:35 GMT -5
via mobile
Post by derekewhitlock on Nov 6, 2018 11:54:35 GMT -5
Does anyone have insights or ideas as to how the new CVS, post Aetna purchase, could affect the sales of Afrezza? Were either CVS or Aetna ‘friendly’ entities as to Afrezza?
|
|
|
CVS
Nov 6, 2018 18:19:03 GMT -5
peppy likes this
Post by aceton3 on Nov 6, 2018 18:19:03 GMT -5
I don't know if they're friendly or not but they have a review section on their pharmacy website with only 7 Afrezza reviews from circa 2015. That seems like it should change. There is a "share your experience" option on the page which posts user reviews. m.cvs.com/drug/afrezza/inhalation-powder/4-8u
|
|
|
Post by sportsrancho on Nov 6, 2018 18:40:36 GMT -5
There’s no 12 unit so that has to be very outdated.
|
|
|
Post by matt on Nov 7, 2018 8:46:54 GMT -5
Does anyone have insights or ideas as to how the new CVS, post Aetna purchase, could affect the sales of Afrezza? Were either CVS or Aetna ‘friendly’ entities as to Afrezza? It really doesn't matter so much if the PBM is "friendly" or not as the ultimate decision on whether a drug is covered is up to the insurance carrier. Some insurers are very generous and use the PBMs to obtain lower handling costs, but the PBM will fill anything they are told to fill. Other insurers are ultra cheap and will use the least expensive solution the PBM can come up with that satisfies the minimum acceptable standard of care. Aetna plans are all over the place because they do a big business in TPA (third-party administration). In a TPA mode, the employer decides what is and is not covered and the insurer complies, taking a fee for managing the paperwork and directly billing the company for the costs incurred. It is really hard to make generalizations about specific providers that offer so many plans funded in so many different ways.
|
|
|
CVS
Nov 7, 2018 9:06:33 GMT -5
via mobile
Post by derekewhitlock on Nov 7, 2018 9:06:33 GMT -5
Thank you for your inputs
|
|